Efficacy and safety of pan-genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir-based antiretroviral therapy.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of viral hepatitis"
DOI: 10.1111/jvh.13844
Abstract: Hepatitis C virus (HCV) infection is more prevalent in people living with HIV-AIDS (PLHA) and portends a poorer prognosis. Pharmacokinetic studies suggest the absence of significant interaction between velpatasvir and dolutegravir which has been recently… read more here.
Keywords: velpatasvir; dolutegravir based; therapy; coinfection dolutegravir ... See more keywords